Michael Scolaro

Michael Scolaro

Dec 23, 2017

Group 6 Copy 278
3
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Are current antibacterial treatments resulting in the evolution of more virulent multidrug resistant bacteria?

Each year in the U.S. 23,000 people die as a direct result of antibiotic resistant infections. I hypothesize...

Making Inexpensive Insulin Using Microalgae

This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae before...

Can we noninvasively measure blood sugar for diabetes?

Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

Backer Badge Funded